180 Life Sciences’s digital transformation strategy involves consolidating critical operational systems to manage complex drug development processes. The company implements specialized platforms for clinical trials, regulatory submissions, and research data to standardize workflows. This approach focuses on integrating data and processes across key scientific and operational functions within the organization.
This transformation creates dependencies on robust data pipelines and system interoperability, making data consistency and workflow automation critical. Challenges include potential data mismatches between integrated systems and delays in reporting due to manual validation steps. This page analyzes specific digital transformation initiatives and their associated operational challenges at 180 Life Sciences.
Forum Markets Snapshot
Headquarters: Palm Beach, United States
Number of employees: 8 employees
Public or private: Public
Business model: B2B
Website: http://www.180lifesciences.com
Forum Markets ICP and Buying Roles
- Highly regulated pharmaceutical and biotechnology companies with complex clinical trial operations.
- Research-intensive organizations requiring integrated data platforms for drug discovery.
Who drives buying decisions
-
Head of Clinical Operations → Oversees clinical trial planning and execution efficiency.
-
Head of Regulatory Affairs → Manages compliance for drug submissions and approvals.
-
VP of Research & Development → Directs scientific discovery and data utilization.
-
Chief Information Officer → Manages core IT infrastructure and system integrations.
Key Digital Transformation Initiatives at Forum Markets (At a Glance)
- Clinical Trial Management System Deployment: Centralizing study planning, site monitoring, and patient enrollment data.
- Clinical Data Management System Integration: Unifying disparate data sources from trials for cleaning and analysis.
- Regulatory Information Management System Implementation: Standardizing document creation, submission, and lifecycle for compliance.
- Research Data Analytics Platform Development: Consolidating preclinical and genomics data for advanced insights.
Where Forum Markets’s Digital Transformation Creates Sales Opportunities
| Vendor Type | Where to Sell (DT Initiative + Challenge) | Buyer / Owner | Solution Approach |
|---|---|---|---|
| Clinical Trial Management (CTM) Software | Clinical Trial Management System Deployment: study startup workflows require manual document preparation across sites. | Head of Clinical Operations, Clinical Project Manager | Route and manage essential study documents for site activation. |
| Clinical Trial Management System Deployment: patient enrollment data does not reconcile across multiple study sites. | Clinical Project Manager, Head of Data Management | Enforce consistent data entry protocols for patient information. | |
| Clinical Trial Management System Deployment: site monitoring reports fail to integrate with central study progress tracking. | Head of Clinical Operations | Standardize data capture from site visits into central systems. | |
| Clinical Data Management (CDM) Platforms | Clinical Data Management System Integration: data discrepancies from electronic data capture (EDC) systems block data analysis. | Head of Data Management, Biostatistician | Validate incoming data against protocol definitions before storage. |
| Clinical Data Management System Integration: manual data reconciliation efforts delay database lock for trial results. | Head of Data Management | Detect and flag inconsistent data points for rapid review. | |
| Clinical Data Management System Integration: fragmented lab results data prevents comprehensive safety reporting. | Pharmacovigilance Lead, Head of Data Management | Centralize and standardize diverse laboratory data formats. | |
| Regulatory Information Management (RIM) Tools | Regulatory Information Management System Implementation: document assembly for submissions requires extensive manual collation. | Head of Regulatory Affairs, Regulatory Operations Manager | Route documents for approval and compile into submission-ready formats. |
| Regulatory Information Management System Implementation: version control issues create incorrect regulatory filings for health authorities. | Regulatory Operations Manager, Compliance Officer | Enforce document versioning and approval workflows for filings. | |
| Regulatory Information Management System Implementation: scattered compliance records hinder audit readiness for new drug applications. | Compliance Officer, Legal Counsel | Standardize storage and access for all regulatory compliance artifacts. | |
| Research Data Integration Platforms | Research Data Analytics Platform Development: siloed genomics data prevents cross-study analysis for drug targets. | VP of Research, Head of Bioinformatics | Unify disparate genomics datasets from various research projects. |
| Research Data Analytics Platform Development: manual data aggregation blocks predictive modeling applications in early discovery. | Head of Bioinformatics, Data Scientist | Standardize data ingress from preclinical studies for machine learning. | |
| Research Data Analytics Platform Development: inconsistent data formats from external partners hinder advanced research analytics. | Data Scientist, Head of IT | Enforce data quality rules for external research data contributions. |
Identify when companies like Forum Markets are in-market for your solutions.
Spot buying signals, find the right prospects, enrich your data, and reach out with relevant messaging at the right time.
What makes this Forum Markets’s digital transformation unique
Forum Markets' (180 Life Sciences) transformation uniquely centers on the rigorous demands of clinical drug development. The company heavily prioritizes data integrity and regulatory compliance, integrating systems that support the stringent requirements of clinical trials and regulatory submissions. This approach makes their transformation more complex, as any system failure directly impacts patient safety, data validity, and potential drug approval timelines. Their focus is not on general efficiency but on precision and auditability within a highly scrutinized environment.
Forum Markets’s Digital Transformation: Operational Breakdown
DT Initiative 1: Clinical Trial Management System (CTMS) Deployment
What the company is doing
The company is rolling out a central system to manage their clinical trials. This system oversees study startup, patient enrollment, and site monitoring activities. It applies across all active clinical studies and investigator sites.
Who owns this
- Head of Clinical Operations
- Clinical Project Managers
- VP of R&D
Where It Fails
- Study startup processes experience delays when manual documentation requires duplicate entry across systems.
- Patient enrollment status does not accurately propagate between clinical sites and central reporting dashboards.
- Site visit reports created by monitors fail to integrate seamlessly with central study progress tracking.
- Investigator payment processing requires manual cross-referencing against trial milestones.
Talk track
Noticed 180 Life Sciences is deploying a Clinical Trial Management System. Been looking at how some biotech teams are standardizing study documentation upfront instead of performing manual reconciliation later, can share what’s working if useful.
DT Initiative 2: Clinical Data Management (CDM) System Integration
What the company is doing
The company is connecting diverse data capture tools into a single platform for clinical data management. This initiative unifies data from electronic case report forms, laboratory results, and imaging systems. It supports data cleaning, validation, and analysis for all clinical trials.
Who owns this
- Head of Data Management
- Biostatisticians
- Clinical Data Scientists
Where It Fails
- Data discrepancies from multiple electronic data capture (EDC) systems create analysis delays for statisticians.
- Manual data reconciliation efforts block the database lock process for trial results.
- Incomplete laboratory results data hinders comprehensive safety reporting to regulatory bodies.
- Data validation rules fail to apply consistently across all incoming data streams from trial sites.
Talk track
Saw 180 Life Sciences is integrating their Clinical Data Management systems. Been looking at how some teams are automating data validation checks before analysis instead of fixing errors downstream, happy to share what we’re seeing.
DT Initiative 3: Regulatory Information Management (RIM) System Implementation
What the company is doing
The company is implementing a system to manage all regulatory information and submissions. This system standardizes the creation, approval, and submission of critical regulatory documents. It applies to all phases of drug development and post-market commitments.
Who owns this
- Head of Regulatory Affairs
- Regulatory Operations Manager
- Compliance Officer
Where It Fails
- Regulatory submission packages require extensive manual collation and formatting before dispatch to health authorities.
- Version control issues create incorrect regulatory filings, leading to potential compliance risks.
- Scattered compliance records compromise audit readiness for critical new drug applications.
- Submission timelines extend when document reviews stall due to fragmented approval workflows.
Talk track
Looks like 180 Life Sciences is implementing a Regulatory Information Management system. Been seeing teams enforce structured document assembly for submissions instead of manual compilation, can share what’s working if useful.
DT Initiative 4: Research Data Analytics Platform Development
What the company is doing
The company is building a unified platform for managing and analyzing research data. This initiative consolidates preclinical study data, genomics information, and biomarker insights. It supports advanced analytics and predictive modeling in drug discovery.
Who owns this
- VP of Research
- Head of Bioinformatics
- Data Scientists
Where It Fails
- Siloed genomics data prevents comprehensive cross-study analysis for identifying drug targets.
- Manual data aggregation from various preclinical studies blocks the application of predictive models.
- Inconsistent data formats from external research partners hinder advanced analytics applications.
- Data lineage tracking fails to record the origin and transformations of key research datasets.
Talk track
Noticed 180 Life Sciences is developing a Research Data Analytics Platform. Been looking at how some research teams are unifying disparate data sources upfront instead of struggling with fragmented insights, happy to share what we’re seeing.
Who Should Target Forum Markets Right Now
This account is relevant for:
- Clinical Trial Management System (CTMS) providers
- Clinical Data Management (CDM) and EDC software vendors
- Regulatory Information Management (RIM) software companies
- Research Data Integration and Analytics platform vendors
- Data Quality and Governance solutions for life sciences
- Pharmacovigilance and Safety Reporting system providers
Not a fit for:
- Generic HR or payroll software
- Basic marketing automation platforms
- E-commerce storefront builders
- General purpose office productivity tools
When Forum Markets Is Worth Prioritizing
Prioritize if:
- You sell solutions for automating manual document preparation in clinical study startup workflows.
- You sell platforms that reconcile patient enrollment data across multiple clinical trial sites.
- You sell systems that validate incoming clinical data against study protocols to prevent discrepancies.
- You sell tools that enforce document version control and approval workflows for regulatory filings.
- You sell solutions that unify disparate genomics and preclinical data for cross-study analysis.
- You sell platforms that track data lineage for critical research datasets.
Deprioritize if:
- Your solution does not address any of the specific breakdowns in clinical, regulatory, or research workflows.
- Your product is limited to basic data management without specific life sciences compliance features.
- Your offering is not built for highly regulated environments with complex data integration needs.
Who Can Sell to Forum Markets Right Now
Clinical Trial Management (CTM) Providers
Veeva Systems - This company offers a suite of cloud-based software for the life sciences industry, including clinical operations and data management.
Why they are relevant: Study startup delays occur due to manual documentation and inconsistent patient enrollment data. Veeva's CTMS can route essential study documents, automate site activation processes, and centralize patient data to enforce consistent tracking across trial sites.
Medidata Solutions (Dassault Systèmes) - This company provides cloud-based solutions for clinical development, including electronic data capture (EDC) and clinical trial management.
Why they are relevant: Site visit reports often fail to integrate with central study progress tracking. Medidata's solutions can standardize data capture from site monitoring activities and ensure seamless integration with the overall clinical trial progress, preventing operational gaps.
Clinical Data Management (CDM) Platforms
Oracle Clinical (or other clinical data management offerings) - This company provides comprehensive software for clinical research, including data capture, management, and analysis.
Why they are relevant: Data discrepancies from multiple EDC systems create significant analysis delays for biostatisticians. Oracle's CDM tools can validate incoming data against protocol definitions, detect inconsistencies, and streamline data cleaning to accelerate database lock.
Pinnacle 21 - This company offers software and services for validating clinical data standards, particularly for regulatory submissions.
Why they are relevant: Manual data reconciliation efforts block the database lock process for trial results. Pinnacle 21 can enforce industry data standards (like CDISC) and identify data issues early, preventing costly manual reconciliation and ensuring data integrity for submission.
Regulatory Information Management (RIM) Solutions
Extedo - This company provides software solutions for electronic regulatory submissions and lifecycle management in the life sciences industry.
Why they are relevant: Regulatory submission packages require extensive manual collation and formatting, leading to delays. Extedo's RIM system can automate document assembly, manage submission components, and ensure compliance with regional regulatory requirements, speeding up critical submissions.
ARIS Global - This company offers cloud-based software for drug safety, regulatory affairs, clinical development, and quality management.
Why they are relevant: Version control issues often create incorrect regulatory filings, posing compliance risks. ARIS Global's RIM capabilities can enforce strict document versioning, manage approval workflows for regulatory documents, and maintain an auditable trail of all filings.
Research Data Integration and Analytics Platforms
Benchling - This company provides a cloud-based R&D platform that unites biology, chemistry, and clinical research data.
Why they are relevant: Siloed genomics data prevents comprehensive cross-study analysis crucial for drug target identification. Benchling can unify disparate genomics datasets from various research projects, enabling integrated analysis and accelerating discovery insights.
Dotmatics - This company offers a scientific R&D platform that integrates data from various experimental workflows across the research lifecycle.
Why they are relevant: Manual data aggregation from preclinical studies blocks the application of predictive models. Dotmatics can standardize data ingress from diverse preclinical sources, facilitating automated data processing for machine learning and advanced analytical applications.
Final Take
Forum Markets (180 Life Sciences) is scaling its core operational systems for clinical trials, regulatory affairs, and research data. Breakdowns are visible in manual data reconciliation, fragmented document workflows, and siloed research insights. This account is a strong fit for vendors whose solutions prevent these specific system failures within a highly regulated life sciences environment.
Identify buying signals from digital transformation at your target companies and find those already in-market.
Find the right contacts and use tailored messages to reach out with context.